Artificial intelligence-based assessment of PD-L1 expression in diffuse large B cell lymphoma
Abstract Diffuse large B cell lymphoma (DLBCL) is an aggressive blood cancer known for its rapid progression and high incidence. The growing use of immunohistochemistry (IHC) has significantly contributed to the detailed cell characterization, thereby playing a crucial role in guiding treatment stra...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-03-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-024-00577-y |